marketcaparena
Search

    IMDX

    Insight Molecular Diagnostics Inc.

    Company overview

    Market capitalization
    $104.06M
    Employees
    55
    Latest publication
    2026-09-29
    About Insight Molecular Diagnostics Inc.

    Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test designed to measure dd-cfDNA using a novel PCR-based measurement platform, for potential patient registrants; GraftAssureIQ, a transplant monitoring assay to measure the donor-derived cell-free DNA; and GraftAssureDx, a decentralized transplant monitoring levels of donor-derived cell-free DNA in plasma following kidney transplantation to aid in the assessment of the probability of allograft rejection at the time of testing in conjunction with standard clinical assessments. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. The company was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue239,000USD32,000USD1,139,000USD260,000USD518,000USD2,138,000USD1,486,000USD115,000USD
    Gross Profit157,000USD-605,500USD496,000USD139,000USD350,000USD1,325,000USD595,000USD50,000USD
    Research Development4,486,000USD4,600,000USD5,829,000USD3,878,000USD3,281,000USD2,924,000USD2,257,000USD2,817,000USD
    Total Operating Expenses11,559,000USD9,725,500USD10,446,000USD11,187,000USD10,192,000USD8,124,000USD34,222,000USD13,565,000USD
    Net Income-11,260,000USD-4,290,000USD-22,955,000USD-10,854,000USD-9,742,000USD-6,671,000USD-33,511,000USD-13,493,000USD
    Cost Of Revenue—637,500USD643,000USD121,000USD168,000USD813,000USD891,000USD65,000USD
    Selling General Administrative—2,991,000USD3,997,000USD2,545,000USD2,647,000USD3,115,000USD3,160,000USD2,565,000USD
    Selling And Marketing Expenses—2,402,000USD385,000USD1,386,000USD1,460,000USD1,206,000USD238,000USD1,043,000USD
    Operating Income—-10,331,000USD-9,950,000USD-11,048,000USD-9,842,000USD-6,799,000USD-33,627,000USD-13,515,000USD
    Interest Expense—23,000USD26,000USD29,000USD25,000USD29,000USD30,000USD31,000USD
    Net Interest Income—-23,000USD-26,000USD-29,000USD-25,000USD-29,000USD-30,000USD-31,000USD
    Income Before Tax—-4,290,000USD-22,955,000USD-10,854,000USD-9,742,000USD-6,671,000USD-33,511,000USD-13,493,000USD
    Tax Provision—0USD—0USD0USD0USD—0USD
    Net Income From Continuing Ops—-4,290,000USD-22,955,000USD-10,854,000USD-9,742,000USD-6,671,000USD-33,511,000USD-13,493,000USD
    Ebit—-10,331,000USD-22,929,000USD-10,825,000USD-9,717,000USD-6,642,000USD-33,481,000USD-13,462,000USD
    Ebitda—-9,700,000USD-22,366,000USD-10,241,000USD-9,158,000USD-6,151,000USD-32,918,000USD-13,122,000USD
    Depreciation And Amortization—631,000USD563,000USD584,000USD559,000USD491,000USD563,000USD340,000USD
    Reconciled Depreciation—631,000USD563,000USD584,000USD559,000USD491,000USD563,000USD340,000USD
    Total Other Income Expense Net—6,041,000USD-13,005,000USD194,000USD100,000USD128,000USD116,000USD22,000USD
    Unclassified Operating Expenses———3,378,000USD2,804,000USD—28,567,000USD7,140,000USD
    Source0001493152-26-036863PreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue4,055,000USD1,881,000USD1,503,000USD958,000USD2,198,000USD1,216,000USD——
    Cost Of Revenue3,865,000USD1,141,000USD1,090,000USD976,000USD778,000USD1,855,000USD344,000USD559,000USD
    Gross Profit190,000USD740,000USD413,000USD-18,000USD1,420,000USD-639,000USD-344,000USD-559,000USD
    Research Development15,900,000USD9,839,000USD9,294,000USD7,301,000USD5,035,000USD9,800,000USD6,794,000USD6,514,000USD
    Selling General Administrative10,633,000USD13,144,000USD12,978,000USD21,516,000USD20,387,000USD16,788,000USD13,281,000USD7,007,000USD
    Unclassified Operating Expenses4,235,000USD38,157,000USD2,970,000USD-10,838,000USD29,718,000USD2,484,000USD——
    Total Operating Expenses30,768,000USD61,781,000USD25,549,000USD17,979,000USD55,145,000USD29,072,000USD22,239,000USD15,202,000USD
    Operating Income-30,578,000USD-61,041,000USD-25,136,000USD-17,997,000USD-53,725,000USD-29,711,000USD-22,239,000USD-15,202,000USD
    Interest Expense109,000USD84,000USD52,000USD83,000USD209,000USD252,000USD299,000USD216,000USD
    Net Interest Income-109,000USD-84,000USD-52,000USD-83,000USD-209,000USD———
    Income Before Tax-50,222,000USD-60,663,000USD-24,855,000USD-18,612,000USD-52,871,000USD-31,186,000USD-22,426,000USD-15,754,000USD
    Net Income-50,222,000USD-60,663,000USD-27,781,000USD-72,902,000USD-64,097,000USD-29,932,000USD-22,329,000USD-15,754,000USD
    Net Income From Continuing Ops-50,222,000USD-60,663,000USD-24,855,000USD-18,612,000USD-43,610,000USD———
    Ebit-30,578,000USD-60,579,000USD-24,803,000USD-18,529,000USD-52,662,000USD-30,934,000USD-22,239,000USD-15,761,000USD
    Ebitda-28,381,000USD-59,015,000USD-23,123,000USD-13,309,000USD-48,457,000USD-30,540,000USD-21,895,000USD-15,202,000USD
    Depreciation And Amortization2,197,000USD1,564,000USD1,680,000USD5,220,000USD4,205,000USD394,000USD344,000USD559,000USD
    Reconciled Depreciation2,197,000USD1,564,000USD1,680,000USD5,220,000USD4,205,000USD———
    Total Other Income Expense Net-19,644,000USD378,000USD281,000USD-615,000USD854,000USD-1,475,000USD-187,000USD-552,000USD
    Selling And Marketing Expenses—641,000USD307,000USD—5,000USD—2,164,000USD1,681,000USD
    Income Tax Expense———54,828,000USD-9,261,000USD-1,254,000USD-97,000USD-336,000USD
    Tax Provision———0USD-9,261,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets29,443,000USD40,427,000USD25,756,000USD43,937,000USD50,517,000USD60,360,000USD35,081,000USD70,216,000USD
    Cash And Equivalents17,756,000USD———————
    Total Current Assets20,543,000USD30,517,000USD15,306,000USD21,389,000USD26,842,000USD36,263,000USD11,759,000USD4,793,000USD
    Total Liabilities50,742,000USD———————
    Total Current Liabilities10,286,000USD12,005,000USD12,075,000USD7,660,000USD6,652,000USD9,683,000USD7,275,000USD9,090,000USD
    Net Receivables-35,000USD157,000USD1,128,000USD258,000USD512,000USD3,540,000USD1,613,000USD209,000USD
    Inventory175,000USD382,000USD446,000USD471,000USD693,000USD459,000USD410,000USD232,000USD
    Property Plant Equipment Net-779,000USD2,459,000USD2,815,000USD2,340,000USD2,524,000USD7,155,000USD2,757,000USD3,001,000USD
    Other Current Assets—1,777,000USD2,149,000USD1,968,000USD1,350,000USD1,235,000USD1,100,000USD989,000USD
    Total Liab—51,118,000USD57,220,000USD53,133,000USD49,419,000USD50,142,000USD47,355,000USD60,505,000USD
    Total Stockholder Equity—-10,691,000USD-31,464,000USD-9,196,000USD1,098,000USD10,218,000USD-12,274,000USD9,711,000USD
    Other Current Liab—8,628,000USD7,724,000USD5,006,000USD3,835,000USD6,000,000USD3,701,000USD6,935,000USD
    Common Stock—394,289,000USD369,211,000USD368,524,000USD367,965,000USD367,387,000USD338,244,000USD326,682,000USD
    Capital Stock—394,289,000USD369,211,000USD368,524,000USD367,965,000USD367,387,000USD338,244,000USD326,682,000USD
    Retained Earnings—-405,051,000USD-400,761,000USD-377,806,000USD-366,952,000USD-357,210,000USD-350,539,000USD-317,028,000USD
    Cash—28,201,000USD11,583,000USD18,692,000USD24,287,000USD31,029,000USD8,636,000USD3,363,000USD
    Cash And Short Term Investments—28,201,000USD11,583,000USD18,692,000USD24,287,000USD31,029,000USD8,636,000USD3,363,000USD
    Net Debt—-25,132,000USD-8,086,000USD-15,565,000USD-20,913,000USD-27,551,000USD-4,972,000USD628,000USD
    Short Term Debt—1,762,000USD1,807,000USD1,598,000USD1,540,000USD1,404,000USD1,295,000USD1,283,000USD
    Short Long Term Debt Total—3,069,000USD3,497,000USD3,127,000USD3,374,000USD3,478,000USD3,664,000USD3,991,000USD
    Accounts Payable—1,615,000USD2,544,000USD1,056,000USD1,277,000USD2,279,000USD2,279,000USD872,000USD
    Property Plant Equipment Gross—19,394,000USD18,904,000USD15,382,000USD14,826,000USD14,588,000USD14,029,000USD13,548,000USD
    Accumulated Other Comprehensive Income—71,000USD86,000USD86,000USD85,000USD41,000USD21,000USD57,000USD
    Common Stock Shares Outstanding—34,519,000shares30,476,000shares32,033,000shares32,023,000shares25,694,000shares17,382,000shares13,714,000shares
    Non Current Assets Total—9,910,000USD10,450,000USD22,548,000USD23,675,000USD24,097,000USD23,322,000USD65,423,000USD
    Non Current Liabilities Total—39,113,000USD45,145,000USD45,473,000USD42,767,000USD40,459,000USD40,080,000USD51,415,000USD
    Non Current Liabilities Other—37,806,000USD43,455,000USD43,944,000USD40,933,000USD38,385,000USD37,711,000USD48,707,000USD
    Non Currrent Assets Other—7,451,000USD7,028,000USD5,608,000USD4,851,000USD642,000USD4,258,000USD4,193,000USD
    Net Working Capital—18,512,000USD3,231,000USD13,729,000USD20,190,000USD26,580,000USD4,484,000USD-4,297,000USD
    Unclassified Non Current Liabilities—1,307,000USD1,690,000USD1,529,000USD1,834,000USD2,074,000USD2,369,000USD2,708,000USD
    Unclassified Equity—-394,289,000USD-369,211,000USD-368,524,000USD-367,965,000USD-367,387,000USD-338,244,000USD-326,682,000USD
    Intangible Assets———14,600,000USD14,600,000USD14,600,000USD14,607,000USD56,529,000USD
    Unclassified Non Current Assets————1,700,000USD1,700,000USD1,700,000USD1,700,000USD
    Source0001493152-26-036863PreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets25,756,000USD35,081,000USD74,892,000USD100,091,000USD159,563,000USD55,419,000USD39,859,000USD9,518,000USD
    Other Current Assets2,149,000USD1,100,000USD782,000USD3,098,000USD3,550,000USD1,205,000USD505,000USD282,000USD
    Total Liab57,220,000USD47,355,000USD54,424,000USD60,497,000USD94,346,000USD21,936,000USD9,021,000USD6,095,000USD
    Total Stockholder Equity-31,464,000USD-12,274,000USD20,468,000USD39,594,000USD65,217,000USD33,483,000USD30,838,000USD3,423,000USD
    Other Current Liab7,724,000USD3,701,000USD5,576,000USD10,038,000USD10,178,000USD5,752,000USD2,386,000USD3,825,000USD
    Common Stock369,211,000USD338,244,000USD310,295,000USD294,929,000USD252,954,000USD157,160,000USD124,583,000USD74,742,000USD
    Capital Stock369,211,000USD338,244,000USD310,295,000USD294,929,000USD252,954,000USD———
    Retained Earnings-400,761,000USD-350,539,000USD-289,876,000USD-260,676,000USD-187,774,000USD-123,677,000USD-93,745,000USD-71,319,000USD
    Cash11,583,000USD8,636,000USD9,432,000USD19,993,000USD32,948,000USD7,143,000USD22,072,000USD8,034,000USD
    Cash And Short Term Investments11,583,000USD8,636,000USD9,432,000USD20,426,000USD33,852,000USD7,818,000USD22,451,000USD8,462,000USD
    Total Current Assets15,306,000USD11,759,000USD10,698,000USD25,536,000USD39,143,000USD9,226,000USD22,956,000USD8,642,000USD
    Total Current Liabilities12,075,000USD7,275,000USD7,194,000USD12,106,000USD14,120,000USD8,996,000USD4,440,000USD5,561,000USD
    Net Debt-8,086,000USD-4,972,000USD-6,563,000USD-16,449,000USD-27,271,000USD1,489,000USD-15,906,000USD-6,315,000USD
    Short Term Debt1,807,000USD1,295,000USD665,000USD815,000USD2,132,000USD2,812,000USD1,585,000USD1,570,000USD
    Short Long Term Debt Total3,497,000USD3,664,000USD2,869,000USD3,544,000USD5,677,000USD8,632,000USD6,166,000USD1,719,000USD
    Net Receivables1,128,000USD1,613,000USD484,000USD2,012,000USD1,437,000USD203,000USD——
    Inventory446,000USD410,000USD0USD2,121,000USD304,000USD———
    Accounts Payable2,544,000USD2,279,000USD953,000USD1,253,000USD1,810,000USD432,000USD469,000USD166,000USD
    Property Plant Equipment Net2,815,000USD2,757,000USD5,436,000USD10,851,000USD8,369,000USD6,524,000USD3,728,000USD614,000USD
    Property Plant Equipment Gross18,904,000USD14,029,000USD11,671,000USD10,851,000USD8,369,000USD———
    Accumulated Other Comprehensive Income86,000USD21,000USD49,000USD39,000USD37,000USD0USD——
    Common Stock Shares Outstanding30,476,000shares13,071,000shares7,651,000shares5,540,000shares4,446,000shares3,273,900shares2,564,800shares1,892,500shares
    Non Current Assets Total10,450,000USD23,322,000USD64,194,000USD74,555,000USD120,420,000USD46,193,000USD16,903,000USD876,000USD
    Non Current Liabilities Total45,145,000USD40,080,000USD47,230,000USD48,391,000USD80,226,000USD12,940,000USD4,581,000USD534,000USD
    Non Current Liabilities Other43,455,000USD37,711,000USD39,900,000USD45,662,000USD76,681,000USD———
    Non Currrent Assets Other7,028,000USD4,258,000USD2,163,000USD2,071,000USD31,646,000USD1,938,000USD2,211,000USD262,000USD
    Net Working Capital3,231,000USD4,484,000USD3,504,000USD13,430,000USD25,023,000USD———
    Unclassified Non Current Liabilities1,690,000USD2,369,000USD7,330,000USD2,729,000USD3,545,000USD12,940,000USD4,581,000USD—
    Unclassified Equity-369,211,000USD-338,244,000USD-310,295,000USD-289,627,000USD-252,954,000USD———
    Intangible Assets—14,607,000USD56,595,000USD61,633,000USD61,721,000USD15,009,000USD——
    Unclassified Non Current Assets—1,700,000USD———13,535,000USD10,964,000USD—
    Short Term Investments——0USD433,000USD904,000USD675,000USD379,000USD428,000USD
    Good Will———0USD18,684,000USD9,187,000USD——
    Unclassified Current Assets———-2,121,000USD————
    Short Long Term Debt————1,313,000USD———
    Long Term Investments————0USD———
    Unclassified Current Liabilities————-1,313,000USD-5,152,000USD——
    Current Deferred Revenue—————5,152,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Net Income-11,260,000USD-4,290,000USD-22,955,000USD-10,854,000USD-9,742,000USD-6,671,000USD-33,511,000USD-13,493,000USD
    Depreciation665,000USD631,000USD563,000USD584,000USD559,000USD491,000USD563,000USD340,000USD
    Stock Based Compensation661,000USD615,000USD721,000USD559,000USD504,000USD487,000USD549,000USD354,000USD
    Investing Cash Flow-779,000USD———————
    Financing Cash Flow-564,000USD———————
    Change In Cash-10,627,000USD16,618,000USD-7,109,000USD-5,777,000USD-6,742,000USD22,393,000USD5,273,000USD-5,893,000USD
    Other Non Cash Items—-5,276,000USD13,538,000USD5,284,000USD2,878,000USD879,000USD28,204,000USD7,088,000USD
    Change To Account Receivables—971,000USD-870,000USD254,000USD3,028,000USD-1,927,000USD-1,404,000USD-124,000USD
    Change To Inventory—64,000USD25,000USD222,000USD-234,000USD-49,000USD-178,000USD-232,000USD
    Change In Working Capital—1,296,000USD2,588,000USD484,000USD-478,000USD-1,044,000USD-1,159,000USD160,000USD
    Total Cash From Operating Activities—-7,639,000USD-5,545,000USD-4,502,000USD-6,279,000USD-5,858,000USD-5,354,000USD-5,551,000USD
    Capital Expenditures—-613,000USD-1,479,000USD-1,050,000USD-349,000USD-307,000USD-214,000USD-215,000USD
    Free Cash Flow—-8,252,000USD-7,024,000USD-5,552,000USD-6,628,000USD-6,165,000USD-5,568,000USD-5,336,000USD
    Total Cashflows From Investing Activities—-613,000USD-1,479,000USD-1,050,000USD-349,000USD-307,000USD-210,000USD-87,000USD
    Net Borrowings—-143,000USD-180,000USD-120,000USD-114,000USD-98,000USD-82,000USD-86,000USD
    Total Cash From Financing Activities—24,698,000USD-252,000USD-120,000USD-114,000USD28,558,000USD10,837,000USD-255,000USD
    Issuance Of Capital Stock—26,024,000USD0USD0USD0USD29,143,000USD11,989,000USD18,000USD
    Begin Period Cash Flow—12,312,000USD19,421,000USD25,987,000USD32,729,000USD10,336,000USD5,063,000USD10,956,000USD
    End Period Cash Flow—28,930,000USD12,312,000USD20,210,000USD25,987,000USD32,729,000USD10,336,000USD5,063,000USD
    Other Cashflows From Investing Activities—-613,000USD——-349,000USD-307,000USD4,000USD-302,000USD
    Other Cashflows From Financing Activities—24,698,000USD-74,000USD—-114,000USD-487,000USD-1,070,000USD-187,000USD
    Unclassified Financing Cash Flow—-25,881,000USD————11,989,000USD—
    Sale Purchase Of Stock——0USD0USD——0USD0USD
    Investments———-1,050,000USD-349,000USD-307,000USD-210,000USD-87,000USD
    Unclassified Investing Cash Flow———1,050,000USD————
    Source0001493152-26-036863PreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-50,222,000USD-60,663,000USD-27,781,000USD-72,902,000USD-64,097,000USD-29,932,000USD-22,426,000USD-15,754,000USD
    Depreciation2,197,000USD1,564,000USD1,680,000USD5,220,000USD4,205,000USD394,000USD351,000USD559,000USD
    Stock Based Compensation2,219,000USD1,913,000USD6,573,000USD10,042,000USD6,841,000USD5,066,000USD2,995,000USD1,479,000USD
    Other Non Cash Items20,895,000USD37,794,000USD174,000USD14,014,000USD26,222,000USD-2,236,000USD437,000USD118,000USD
    Change To Account Receivables485,000USD-1,129,000USD109,000USD-575,000USD-1,229,000USD-182,000USD——
    Change To Inventory-36,000USD-410,000USD0USD—————
    Change In Working Capital2,727,000USD-1,321,000USD-3,971,000USD-1,942,000USD149,000USD1,982,000USD-1,555,000USD993,000USD
    Total Cash From Operating Activities-22,184,000USD-20,713,000USD-23,325,000USD-45,568,000USD-35,941,000USD-25,980,000USD-19,715,000USD-11,649,000USD
    Capital Expenditures-3,185,000USD-516,000USD-281,000USD-4,340,000USD-2,247,000USD-1,227,000USD-918,000USD-31,000USD
    Free Cash Flow-25,369,000USD-21,229,000USD-23,606,000USD-49,908,000USD-38,188,000USD-27,207,000USD-20,633,000USD-11,680,000USD
    Total Cashflows From Investing Activities-3,185,000USD-512,000USD-932,000USD-4,340,000USD-13,961,000USD-11,748,000USD-12,415,000USD-31,000USD
    Net Borrowings-512,000USD-201,000USD-117,000USD-1,429,000USD-1,534,000USD———
    Total Cash From Financing Activities28,072,000USD20,429,000USD12,186,000USD35,806,000USD78,364,000USD22,799,000USD47,868,000USD12,114,000USD
    Sale Purchase Of Stock0USD-5,389,000USD-1,118,000USD0USD-239,000USD-14,000USD——
    Issuance Of Capital Stock29,143,000USD27,814,000USD13,848,000USD37,718,000USD77,987,000USD———
    Change In Cash3,676,000USD-796,000USD-12,071,000USD-14,102,000USD28,462,000USD-14,929,000USD15,738,000USD434,000USD
    Begin Period Cash Flow8,636,000USD11,132,000USD23,203,000USD37,305,000USD8,843,000USD23,772,000USD8,034,000USD7,600,000USD
    End Period Cash Flow12,312,000USD10,336,000USD11,132,000USD23,203,000USD37,305,000USD8,843,000USD23,772,000USD8,034,000USD
    Other Cashflows From Financing Activities-74,000USD-7,184,000USD-1,545,000USD4,392,000USD2,150,000USD1,313,000USD-2,345,000USD-201,000USD
    Unclassified Financing Cash Flow28,658,000USD33,203,000USD14,966,000USD32,843,000USD77,987,000USD21,500,000USD50,213,000USD12,411,000USD
    Investments—-512,000USD-932,000USD-4,340,000USD-13,961,000USD———
    Other Cashflows From Investing Activities—4,000USD-1,018,000USD-4,340,000USD-13,354,000USD-7,000USD-252,000USD-240,000USD
    Unclassified Investing Cash Flow——1,299,000USD8,680,000USD15,601,000USD-10,514,000USD-11,245,000USD—
    Unclassified Operating Cash Flow————-9,261,000USD-1,254,000USD——
    Dividends Paid———————-96,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductKitted Products0USD0001642380-26-000008
    Q1 2026Quarterly · 2026-03-31ProductLaboratory Services32,000USD0001642380-26-000008
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific0USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31GeographyEurope24,000USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31GeographyUnited Kingdom0USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31GeographyUnited States4,031,000USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31ProductKitted Products24,000USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31ProductLaboratory Developed Test Services0USD0001642380-26-000004
    FY 2025Yearly · 2025-12-31ProductLaboratory Services4,031,000USD0001642380-26-000004
    Q3 2025Quarterly · 2025-09-30ProductKitted Products0USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30ProductLaboratory Developed Test Services0USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30ProductLaboratory Services260,000USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific0USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30GeographyEurope0USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30GeographyUnited Kingdom0USD0001193125-25-274266
    Q3 2025Quarterly · 2025-09-30GeographyUnited States260,000USD0001193125-25-274266
    Q2 2025Quarterly · 2025-06-30ProductKitted Products24,000USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30ProductLaboratory Developed Test Services0USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30ProductLaboratory Services494,000USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific0USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30GeographyEurope24,000USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30GeographyUnited Kingdom0USD0000950170-25-106552
    Q2 2025Quarterly · 2025-06-30GeographyUnited States494,000USD0000950170-25-106552
    Q1 2025Quarterly · 2025-03-31ProductKitted Products0USD0001642380-26-000008
    Q1 2025Quarterly · 2025-03-31ProductLaboratory Services2,138,000USD0001642380-26-000008
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific0USD0000950170-25-069213
    Q1 2025Quarterly · 2025-03-31GeographyUnited Kingdom0USD0000950170-25-069213
    Q1 2025Quarterly · 2025-03-31GeographyUnited States2,138,000USD0000950170-25-069213
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific145,000USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31GeographyEurope18,000USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31GeographyUnited Kingdom45,000USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31GeographyUnited States1,673,000USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31ProductKitted Products0USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31ProductLaboratory Developed Test Services22,000USD0001642380-26-000004
    FY 2024Yearly · 2024-12-31ProductLaboratory Services1,859,000USD0001642380-26-000004
    Q3 2024Quarterly · 2024-09-30ProductKitted Products0USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30ProductLaboratory Developed Test Services0USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30ProductLaboratory Services115,000USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific0USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30GeographyEurope0USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30GeographyUnited Kingdom0USD0001193125-25-274266
    Q3 2024Quarterly · 2024-09-30GeographyUnited States115,000USD0001193125-25-274266
    Q2 2024Quarterly · 2024-06-30ProductKitted Products0USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30ProductLaboratory Developed Test Services0USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30ProductLaboratory Services104,000USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific37,000USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30GeographyEurope0USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30GeographyUnited Kingdom0USD0000950170-25-106552
    Q2 2024Quarterly · 2024-06-30GeographyUnited States67,000USD0000950170-25-106552
    Q1 2024Quarterly · 2024-03-31ProductLaboratory Developed Test Services22,000USD0000950170-25-069213
    Q1 2024Quarterly · 2024-03-31ProductPharma Services154,000USD0000950170-25-069213
    Q1 2024Quarterly · 2024-03-31GeographyAsia Pacific109,000USD0000950170-25-069213
    Q1 2024Quarterly · 2024-03-31GeographyUnited Kingdom45,000USD0000950170-25-069213
    Q1 2024Quarterly · 2024-03-31GeographyUnited States22,000USD0000950170-25-069213
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific160,000USD0000950170-25-043852
    FY 2023Yearly · 2023-12-31GeographyES11,000USD0000950170-25-043852
    FY 2023Yearly · 2023-12-31GeographyUnited Kingdom409,000USD0000950170-25-043852
    FY 2023Yearly · 2023-12-31GeographyUnited States923,000USD0000950170-25-043852
    FY 2023Yearly · 2023-12-31ProductLaboratory Developed Test Services36,000USD0000950170-25-043852
    FY 2023Yearly · 2023-12-31ProductPharma Services1,467,000USD0000950170-25-043852

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.